ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of Medisorb® naltrexone
(VIVITROL®) when administered over a period of 24 months to health care professionals who
have a history of opioid dependence.